PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), 1mg/mL

Produktübersicht

• Artikelname: PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), 1mg/mL
• Artikelnummer: BOT-BNUM2743-50
• Hersteller Artikelnummer: BNUM2743-50
• Alternativnummer: BOT-BNUM2743-50-50UL
• Hersteller: Biotium
• Kategorie: Antikörper
• Applikation: FC, IF

Produktbeschreibung

PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activate

Produkteigenschaften

• Konzentration: 1 mg/mL
• Puffer: PBS, no BSA, no azide
• Quelle: Animal